Background
We hypothesized that Nox2 plays an important role in cyclosporine A (CsA)-induced chronic hypoxia.
Methods
We tested this hypothesis in Fisher 344 rats, C57BL/6J wild type and Nox2−/− mice, and in liver transplant recipients with chronic CsA nephrotoxicity. We used noninvasive molecular imaging (BOLD and DCE MRI) and molecular diagnostic tools to assess intrarenal oxygenation and perfusion, and the molecular phenotype of CsA nephrotoxicity.
Results
We observed that chemical and genetic inhibition of Nox2 in rats and mice resulted in the prevention of CsA-induced hypoxia independent of regional perfusion (BOLD and DCE MRI, pimonidazole, HIF1-α). Nox2 knockout was also associated with decreased oxidative stress (Nox2, HIF-1α, hydrogen peroxide, HNE), and fibrogenesis (α-SMA, picrosirius red, trichrome, vimentin). The molecular signature of chronic CsA nephrotoxicity using transcriptomic analyses demonstrated significant changes in 40 genes involved in injury-repair, metabolism, and oxidative stress in Nox2−/− mice. Immunohistochemical analyses of kidney biopsies from liver transplant recipients with chronic CsA nephrotoxicity showed significantly greater Nox2, α-SMA and picrosirius levels compared to controls.
Conclusions
These studies suggest that Nox2 is a modulator of CsA-induced hypoxia upstream of HIF-1α, and define the molecular characteristics that could be used for the diagnosis and monitoring of chronic CNI nephrotoxicity.